Technical Analysis for ASRT - Assertio Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.2 -0.47% -0.02
ASRT closed down 0.47 percent on Thursday, January 17, 2019, on 23 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ASRT trend table...

Date Alert Name Type % Chg
Jan 17 NR7 Range Contraction 0.00%
Jan 17 Inside Day Range Contraction 0.00%
Jan 16 Outside Day Range Expansion -0.47%
Jan 15 NR7 Range Contraction -1.18%
Jan 15 NR7-2 Range Contraction -1.18%
Jan 14 NR7 Range Contraction -0.47%
Jan 10 Overbought Stochastic Strength 1.69%
Jan 9 Bearish Engulfing Bearish 2.44%
Jan 9 New Downtrend Bearish 2.44%
Jan 9 Stochastic Sell Signal Bearish 2.44%

Older signals for ASRT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution), Xartemis XR and Zipsor (diclofenac potassium). Its NUCYNTA ER (tapentadol extended release tablets) is a product for the management of pain severe enough to require daily long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults, and its NUCYNTA (tapentadol) is a product for the management of moderate to severe acute pain in adults. Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia (PHN). Its Cambia (diclofenac potassium for oral solution) is a product for the acute treatment of migraine attacks.
Is ASRT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.48
52 Week Low 3.37
Average Volume 1,020,924
200-Day Moving Average 6.2175
50-Day Moving Average 4.5468
20-Day Moving Average 3.9755
10-Day Moving Average 4.223
Average True Range 0.2579
ADX 19.54
+DI 18.5599
-DI 18.582
Chandelier Exit (Long, 3 ATRs ) 3.8163
Chandelier Exit (Short, 3 ATRs ) 4.1437
Upper Bollinger Band 4.5332
Lower Bollinger Band 3.4178
Percent B (%b) 0.7
BandWidth 28.056848
MACD Line -0.0513
MACD Signal Line -0.1266
MACD Histogram 0.0753
Fundamentals Value
Market Cap 264.55 Million
Num Shares 63 Million
EPS -1.79
Price-to-Earnings (P/E) Ratio -2.35
Price-to-Sales 0.75
Price-to-Book 1.50
PEG Ratio 0.46
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.40
Resistance 3 (R3) 4.39 4.33 4.36
Resistance 2 (R2) 4.33 4.28 4.33 4.35
Resistance 1 (R1) 4.26 4.25 4.23 4.27 4.34
Pivot Point 4.20 4.20 4.18 4.20 4.20
Support 1 (S1) 4.13 4.15 4.10 4.14 4.06
Support 2 (S2) 4.07 4.12 4.07 4.05
Support 3 (S3) 4.00 4.07 4.04
Support 4 (S4) 4.01